The top line beat the Zacks Consensus Estimate of $711.9 million. Product revenues totaled $735.6 million, which rose 16% year over year on higher revenues from Voxzogo, Vimizim, Naglazyme and ...
Copyright (C) 2022 by nekohasekai <[email protected]> This program is free software: you can redistribute it and/or modify it under the terms of the GNU ...
Bavarian Nordic has licensed rights to its respiratory syncytial virus (RSV) vaccine in China and certain other Asian markets to Shanghai's Nuance Pharma in a $225 million deal. The agreement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback